Guest guest Posted September 19, 2008 Report Share Posted September 19, 2008 * Study of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL) (Rev-CLL) This study is currently recruiting participants. http://clinicaltrials.gov/ct2/show/NCT00751296 * Ofatumumab-Chlorambucil Combination vs. Chlorambucil Monotherapy in Previously Untreated Patients With Chronic Lymphocytic Leukemia This study is not yet open for participant recruitment. Ofatumumab is a new humanized anti-cd20 antibody http://clinicaltrials.gov/ct2/show/NCT00748189 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.